Literature DB >> 25599955

Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease.

Piero Ruscitti1, Paola Cipriani2, Paola Di Benedetto2, Francesco Ciccia3, Vasiliki Liakouli2, Francesco Carubbi2, Onorina Berardicurti2, Aroldo Rizzo4, Giovanni Triolo3, Roberto Giacomelli2.   

Abstract

In this paper, we aimed to evaluate the levels of ferritin enriched in H subunits (H-ferritin) and ferritin enriched in L subunits (L-ferritin) and the cells expressing these 2 molecules, in the bone marrow (BM) and liver biopsies obtained from adult onset Still's disease (AOSD) patients who developed macrophage activation syndrome (MAS), and correlating these data with the severity of the disease. Twenty-one patients with MAS-associated AOSD underwent BM biopsy and among them, 9 patients with hepatomegaly and elevated liver enzymes underwent liver biopsy. All the samples were stained by both immunohistochemistry and immunofluorescence. A statistical analysis was performed to estimate the possible correlation among both H-ferritin and L-ferritin tissue expression and the clinical picture of the disease. Furthermore, the same analysis was performed to evaluate the possible correlation among the number of CD68/H-ferritin or CD68/L-ferritin positive cells and the clinical picture. Both immunohistochemical and immunofluorescence analysis demonstrated an increased tissue H-ferritin expression, in the BM and liver samples of our patients. This increased expression correlated with the severity of the disease. An inflammatory infiltrate, enriched in CD68 macrophages, expressing H-ferritin was observed in both the BM and the liver samples of our patients. Furthermore, we observed, that this increased number of CD68/H-ferritin positive cells significantly correlated with the severity of clinical picture and this specific BM infiltrate correlated with the mortality rate, reported in our cohort. Our data showed an imbalance between the levels of H- and L-ferritin in different organs of patients with MAS-associated AOSD and the evidence of a strong infiltrate of CD68/H-ferritin positive cells in the same organs. Furthermore, a strong correlation among both the tissue H-ferritin and the CD68/H-ferritin positive cells and the clinical picture was observed.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adult-onset Still's disease; Hyperferritinemia; Macrophage activation syndrome

Mesh:

Substances:

Year:  2015        PMID: 25599955     DOI: 10.1016/j.autrev.2015.01.004

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  17 in total

1.  The CD68(+)/H-ferritin(+) cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: correlation with disease severity and implication for pathogenesis.

Authors:  P Ruscitti; F Ciccia; P Cipriani; G Guggino; P Di Benedetto; A Rizzo; V Liakouli; O Berardicurti; F Carubbi; G Triolo; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2015-12-08       Impact factor: 4.330

2.  Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients.

Authors:  Piero Ruscitti; Carmela Rago; Luciana Breda; Paola Cipriani; Vasiliki Liakouli; Onorina Berardicurti; Francesco Carubbi; Caterina Di Battista; Alberto Verrotti; Roberto Giacomelli
Journal:  Clin Rheumatol       Date:  2017-09-15       Impact factor: 2.980

3.  H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome.

Authors:  P Ruscitti; P Cipriani; P Di Benedetto; V Liakouli; O Berardicurti; F Carubbi; F Ciccia; G Guggino; G Triolo; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2017-10-20       Impact factor: 4.330

4.  H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease.

Authors:  P Ruscitti; P Cipriani; F Ciccia; P Di Benedetto; V Liakouli; O Berardicurti; F Carubbi; G Guggino; S Di Bartolomeo; G Triolo; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2016-07-28       Impact factor: 4.330

5.  The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.

Authors:  Der-Yuan Chen; Yi-Ming Chen; Chi-Chen Lin; Chia-Wei Hsieh; Yen-Ching Wu; Wei-Ting Hung; Hsin-Hua Chen; Joung-Liang Lan
Journal:  BMC Musculoskelet Disord       Date:  2015-05-09       Impact factor: 2.362

6.  Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers.

Authors:  Piero Ruscitti; Paola Cipriani; Francesco Masedu; Daniela Iacono; Francesco Ciccia; Vasiliki Liakouli; Giuliana Guggino; Francesco Carubbi; Onorina Berardicurti; Paola Di Benedetto; Marco Valenti; Giovanni Triolo; Gabriele Valentini; Roberto Giacomelli
Journal:  BMC Med       Date:  2016-12-01       Impact factor: 8.775

Review 7.  Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm.

Authors:  Piero Ruscitti; Onorina Berardicurti; Paola Di Benedetto; Paola Cipriani; Annamaria Iagnocco; Yehuda Shoenfeld; Roberto Giacomelli
Journal:  Front Immunol       Date:  2020-05-28       Impact factor: 7.561

8.  Limited diagnostic value of procalcitonin in early diagnosis of adult onset Still's disease.

Authors:  Ewelina Gowin; Jacek Wysocki
Journal:  Reumatologia       Date:  2016-10-05

9.  Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations.

Authors:  Piero Ruscitti; Paola Di Benedetto; Onorina Berardicurti; Noemi Panzera; Nicolò Grazia; Anna Rita Lizzi; Paola Cipriani; Yehuda Shoenfeld; Roberto Giacomelli
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379

Review 10.  Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions.

Authors:  Yvan Jamilloux; Thomas Henry; Alexandre Belot; Sébastien Viel; Maxime Fauter; Thomas El Jammal; Thierry Walzer; Bruno François; Pascal Sève
Journal:  Autoimmun Rev       Date:  2020-05-04       Impact factor: 9.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.